Viewing Study NCT07194005


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-01-15 @ 3:24 PM
Study NCT ID: NCT07194005
Status: RECRUITING
Last Update Posted: 2025-09-26
First Post: 2025-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module